TI
TARO

Trexquant Investment’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Trexquant Investment’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,840
Closed -$290K – 1934
2024
Q1 		$290K Buy
+6,840
New +$288K 0.01% 1295
2019
Q3 		– Sell
-3,944
Closed -$337K – 1165
2019
Q2 		$337K Buy
+3,944
New +$390K 0.03% 567
2018
Q2 		– Sell
-6,316
Closed -$624K – 1301
2018
Q1 		$624K Buy
6,316
+1,574
+33% +$159K 0.04% 561
2017
Q4 		$497K Buy
+4,742
New +$521K 0.05% 513
2015
Q4 		– Sell
-1,900
Closed -$271K – 1320
2015
Q3 		$271K Sell
1,900
-9,430
-83% -$1.32M 0.02% 904
2015
Q2 		$1.63M Buy
+11,330
New +$1.62M 0.18% 158

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Trexquant Investment's TARO Position: Q2 2024 in Review

Trexquant Investment sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 6,840 shares — an estimated $290K sold.

Trexquant Investment first reported a position in TARO in Q2 2015 and held it in 6 quarters. The position peaked at $1.63M in Q2 2015. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Trexquant Investment reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Trexquant Investment sold 6,840 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $290K.
  • Trexquant Investment first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 6 quarters.
  • Trexquant Investment's Taro Pharmaceutical Industries Ltd. position peaked at $1.63M in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.